Guillain-Barré syndrome following allogeneic hematopoietic stem cell transplantation in a pediatric patient: a case report and literature review

Jia-Yi LYU, Xiao-Hui ZHOU, Chun-Jing WANG, Chun-Lan YANG, Ming-Jing LUO, Si-Xi LIU

Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 763-767.

PDF(545 KB)
PDF(545 KB)
Chinese Journal of Contemporary Pediatrics ›› 2026, Vol. 28 ›› Issue (6) : 763-767. DOI: 10.7499/j.issn.1008-8830.2509140
CASE REPORT

Guillain-Barré syndrome following allogeneic hematopoietic stem cell transplantation in a pediatric patient: a case report and literature review

Author information +
History +

Abstract

A 10-year-old girl diagnosed with hyper-IgE syndrome for more than six years developed dizziness and symmetrical progressive limb weakness one week prior to hospital admission, occurring 4 months after allogeneic hematopoietic stem cell transplantation. On post-transplant day 121, dizziness and progressive, symmetric limb weakness appeared. Cerebrospinal fluid analysis revealed albuminocytologic dissociation. Electromyography confirmed multiple peripheral nerve lesions, consistent with the diagnosis of Guillain-Barré syndrome. Intravenous immunoglobulin therapy showed limited efficacy, whereas corticosteroid therapy produced significant clinical improvement. Neurological symptoms fully resolved after treatment; however, severe chronic graft-versus-host disease occurred subsequently. Based on this case, related literature was reviewed and summarized to provide references for early diagnosis, mechanistic investigation, and treatment options.

Key words

Allogeneic hematopoietic stem cell transplantation / Guillain-Barré syndrome / Graft-versus-host disease / Child

Cite this article

Download Citations
Jia-Yi LYU , Xiao-Hui ZHOU , Chun-Jing WANG , et al . Guillain-Barré syndrome following allogeneic hematopoietic stem cell transplantation in a pediatric patient: a case report and literature review[J]. Chinese Journal of Contemporary Pediatrics. 2026, 28(6): 763-767 https://doi.org/10.7499/j.issn.1008-8830.2509140

References

[1]
中华医学会神经病学分会, 中华医学会神经病学分会周围神经病协作组. 中国吉兰—巴雷综合征诊治指南2024[J]. 中华神经科杂志, 2024, 57(9): 936-944. DOI: 10.3760/cma.j.cn113694-20240220-00099 .
[2]
Leonhard SE, van der Eijk AA, Willison HJ, et al. Author response: an international perspective on preceding infections in Guillain-Barré syndrome: the IGOS-1000 cohort[J]. Neurology, 2023, 100(5): 264. DOI: 10.1212/WNL.0000000000206817 .
[3]
Shahrizaila N, Lehmann HC, Kuwabara S. Guillain-Barré syndrome[J]. Lancet, 2021, 397(10280): 1214-1228. DOI: 10.1016/S0140-6736(21)00517-1 .
[4]
Ren XY, Liu X, Huang QS, et al. Incidence, risk factors, and outcome of immune-mediated neuropathies (IMNs) following haploidentical hematopoietic stem cell transplantation[J]. Biol Blood Marrow Transplant, 2019, 25(8): 1629-1636. DOI: 10.1016/j.bbmt.2019.04.021 .
[5]
Karam C, Mauermann ML, Johnston PB, et al. Immune-mediated neuropathies following stem cell transplantation[J]. J Neurol Neurosurg Psychiatry, 2014, 85(6): 638-642. DOI: 10.1136/jnnp-2013-306657 .
[6]
石亚军, 汉英, 王莹, 等. 异基因造血干细胞移植后合并吉兰—巴雷综合征1例报告并文献复习[J]. 中华血液学杂志, 2024, 45(5): 509-511. PMCID: PMC11270495. DOI: 10.3760/cma.j.cn121090-20231020-00222 .
[7]
Rodriguez V, Kuehnle I, Heslop HE, et al. Guillain-Barré syndrome after allogeneic hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2002, 29(6): 515-517. DOI: 10.1038/sj.bmt.1703412 .
[8]
Nasiri A, Alshammari T, Alsolaihim A, et al. Tacrolimus associated Guillain-Barre syndrome[J]. Arch Clin Cases, 2025, 12(2): 75-79. PMCID: PMC12096302. DOI: 10.22551/2025.47.1202.10317 .
[9]
Thöne J, Lamprecht S, Hohaus A, et al. Guillain-Barré syndrome as leading manifestation of graft-versus-host disease in an allogeneic bone marrow transplanted patient[J]. J Neurol Sci, 2010, 292(1/2): 114-116. DOI: 10.1016/j.jns.2010.01.020 .
[10]
Yoshida T, Ueki Y, Suzuki T, et al. Guillain-Barré syndrome after allogeneic bone marrow transplantation: case report and literature review[J]. eNeurologicalSci, 2016, 4: 52-55. PMCID: PMC5803090. DOI: 10.1016/j.ensci.2016.08.001 .
[11]
Gonzalez Vicent M, Molina B, Fabregat M, et al. Toxoplasmosis and secondary Guillain-Barré associated with ruxolitinib as graft-versus-host disease treatment[J]. Pediatr Blood Cancer, 2019, 66(1): e27446. DOI: 10.1002/pbc.27446 .
[12]
周静东, 王芸, 冯媛, 等. 急性髓系白血病脐血移植后并发肾病综合征伴格林-巴利综合征1例[J]. 中国肿瘤临床, 2024, 51(12): 647-648. DOI: 10.12354/j.issn.1000-8179.2024.20240472 .
[13]
Raboni SM, Bonfim C, Almeida BM, et al. Flavivirus cross-reactivity in serological tests and Guillain-Barré syndrome in a hematopoietic stem cell transplant patient: a case report[J]. Transpl Infect Dis, 2017, 19(4): e12700. DOI: 10.1111/tid.12700 .
[14]
Bitan M, Or R, Shapira MY, et al. Early-onset Guillain-Barré syndrome associated with reactivation of Epstein-Barr virus infection after nonmyeloablative stem cell transplantation[J]. Clin Infect Dis, 2004, 39(7): 1076-1078. DOI: 10.1086/424015 .
[15]
Fujisaki G, Kami M, Murashige N, et al. Guillain-Barre syndrome associated with rapid immune reconstitution following allogeneic hematopoietic stem cell transplantation[J]. Bone Marrow Transplant, 2006, 37(6): 617-619. DOI: 10.1038/sj.bmt.1705283 .
[16]
许晓倩, 贾麟, 陈莉, 等. 异基因造血干细胞移植后并发格林-巴利综合征二例报告并文献复习[J]. 中华血液学杂志, 2014, 35(8): 694-697. DOI: 10.3760/cma.j.issn.0253-2727.2014.08.005 .

Footnotes

所有作者均声明无利益冲突。

PDF(545 KB)

Accesses

Citation

Detail

Sections
Recommended

/